Combined Efficacy and Safety of an Early, Intensive, Management Strategy With Finerenone and SGLT2 Inhibitor in Patients Hospitalized With Heart Failure (CONFIRMATION-HF)
Combined Efficacy and Safety of an Early, Intensive, Management Strategy With Finerenone and SGLT2 Inhibitor in Patients Hospitalized With Heart Failure (CONFIRMATION-HF)
Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure.
This is an international, randomized, controlled, open-label, trial of an early, intensive management strategy using the combination of finerenone plus sodium-glucose co-transporter 2 inhibitor (SGLT2i) compared with usual care in patients hospitalized with heart failure (HF).
Inclusion Criteria:
Exclusion Criteria:
info@cpcmed.org(303) 860-9900
Caxias do Sul, Rio Grande do Sul 95070560, Brazil
Joinville, Santa Catarina 89200-000, Brazil
Bragança Paulista, São Paulo 12916542, Brazil
Presidente Prudente, São Paulo 19050-680, Brazil
São Paulo, São Paulo 05652-900, Brazil
North York, Ontario M6B 3H7, Canada
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org3038609900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org3038609900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org3038609900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org3038609900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org3038609900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org3038609900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900
info@cpcmed.org+1-303-860-9900